Ceramed offers CeraDOSE®, a blood‑based diagnostic that measures ceramide biomarkers to predict a patient’s response to specific antidepressants and suggest optimal dosing. The test results are processed through a cloud analytics engine and delivered via a FHIR‑compatible platform that integrates directly into electronic health records, giving clinicians actionable guidance to personalize depression treatment.
Funding
Funding not disclosed
Founders
Product
Problem
Major depressive disorder treatment relies on trial-and-error prescribing of antidepressants, with no objective biomarkers to predict patient response or guide dosing. Consequently, about half of patients do not respond to first‑line therapy and many experience relapse, leading to substantial personal and economic costs.
Solution
Ceramed has developed CeraDOSE®, a blood‑based diagnostic that quantifies specific ceramide biomarkers to forecast an individual’s likely response to a given antidepressant. After a simple venipuncture, the sample is analyzed and the results are uploaded to a FHIR‑compatible cloud platform, where an algorithm interprets the ceramide profile and provides clinicians with a treatment suitability score and dosing guidance. This enables psychiatrists to select the most effective medication early in the care pathway, reduce unnecessary medication switches, and personalize dosage to improve outcomes. By integrating the test results into existing electronic health record workflows, CeraDOSE® supports data‑driven decision‑making without disrupting clinical routines.
Target Audience
Primary customers are psychiatrists, primary care physicians, and mental health clinics that prescribe antidepressants and seek objective tools to personalize treatment for patients with major depressive disorder.
Features
- Blood draw assay measuring a validated panel of ceramide biomarkers linked to antidepressant efficacy
- Cloud‑based analytics engine that generates a predictive response score and dosing recommendation within hours
- FHIR‑native integration allowing seamless import of test results into major EHR systems
- Clinician dashboard presenting biomarker levels, confidence intervals, and actionable treatment suggestions
- Regulatory‑compliant data handling ensuring patient privacy and secure transmission of results